Staar Surgical (STAA) Invested Capital (2010 - 2026)

Staar Surgical (STAA) has 17 years of Invested Capital data on file, last reported at $352.4 million in Q2 2026.

• For the quarter ending Q2 2026, Invested Capital rose 0.68% year-over-year to $352.4 million; the trailing twelve-month figure through Apr 2026 stood at $352.4 million (up 0.68% YoY), and the FY2026 full-year result was $344.2 million, down 13.38% from the prior year.
• Invested Capital for Q2 2026 stood at $352.4 million, up from $344.2 million in the prior quarter.
• Across five years, Invested Capital topped out at $428.1 million in Q3 2024 and bottomed at $276.3 million in Q2 2022.
• The 5-year median for Invested Capital is $352.4 million (2026), against an average of $356.9 million.
• The widest annual swing landed in 2022, when Invested Capital grew 29.06%; it then declined 17.73% in 2025.
• A 5-year view of Invested Capital shows it stood at $336.1 million in 2022, then advanced by 14.83% to $386.0 million in 2023, then advanced by 2.95% to $397.3 million in 2024, then slipped by 10.96% to $353.8 million in 2025, then declined by 0.4% to $352.4 million in 2026.
• The last three Invested Capital figures came in at $352.4 million (Q2 2026), $344.2 million (Q1 2026), and $353.8 million (Q3 2025), per Business Quant data.

Peer Comparison